Aizant Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AIZANT, and what generic and branded alternatives to AIZANT drugs are available?
AIZANT has four approved drugs.
There are three tentative approvals on AIZANT drugs.
Drugs and US Patents for Aizant
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aizant | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 210948-002 | Mar 15, 2019 | BX | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Aizant | PIRFENIDONE | pirfenidone | TABLET;ORAL | 212747-001 | Jul 21, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Aizant | ELIGLUSTAT TARTRATE | eliglustat tartrate | CAPSULE;ORAL | 212463-001 | Sep 8, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.